Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
We have cloned and characterized a human cDNA that belongs to the histone deacetylase family, which we designate as HDAC11. The predicted HDAC11 amino acid sequence reveals an open reading frame of 347 residues with a corresponding molecular mass of 39 kDa. Sequence analyses of the putative HDAC11 protein indicate that it contains conserved residues in the catalytic core regions shared by both class I and II mammalian HDAC enzymes. Putative orthologues of HDAC11 exist in primate, mouse, Drosophila, and plant. Epitope-tagged HDAC11 protein expressed in mammalian cells displays histone deacetylase activity in vitro. Furthermore, HDAC11's enzymatic activity is inhibited by trapoxin, a known histone deacetylase inhibitor. Multiple tissue Northern blot and real-time PCR experiments show that the high expression level of HDAC11 transcripts is limited to kidney, heart, brain, skeletal muscle, and testis. Epitope-tagged HDAC11 protein localizes predominantly to the cell nucleus. Co-immunoprecipitation experiments indicate that HDAC11 may be present in protein complexes that also contain HDAC6. These results indicate that HDAC11 is a novel and unique member of the histone deacetylase family and it may have distinct physiological roles from those of the known HDACs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two related classes of eukaryotic zinc-containing HDACs have been recognized based upon sequence similarity: class I (HDAC1, 2, 3, and 8) and class II (HDAC4, 5, 6, 7, 9, and 10) (Johnstone, 2002; Gao et al., 2002).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Gao et al., 2002
In the citing paper
“It has been shown to associate with HDAC6 (Gao et al., 2002; Cheng et al., 2014)”
From Histone deacetylase 11 is an ε-N-Myristoyllysine hydrolase (2018) · cites this paper as Gao et al., 2002
In the citing paper
“HDAC11 is a newly identified member of the HDAC family and thus far no known physiological function for HDAC11 has been demonstrated23.”
From The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance (2009) · cites this paper as [23]
Citations
Cites
Crystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase
Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80218-4 · Cited by 1,230
Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L.-F., Fischle, W., Verdin, E., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,222
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
McKinsey, T. A., Zhang, C.-L., Lu, J., & Olson, E. N. (2000) · Nature · doi:10.1038/35040593 · Cited by 1,052
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Research works printed but not linked: 2
- Van Lint, 1996, Gene Expr., 5, 245
- Fischle, 2001, Biochem. Cell Biol., 79, 337, 10.1139/o01-116 · DOI · Paper page
Cited by
Items 201–300 of 761
Zhou, Y., Peng, J., & Jiang, S. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2014.03.001 · Cited by 78
Microtubule associated proteins as targets for anticancer drug development
Khwaja, S., Kumar, K., Das, R., & Negi, A. S. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105320 · Cited by 82
Aminoglycoside‐induced histone deacetylation and hair cell death in the mouse cochlea
Chen, F., Schacht, J., & Sha, S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05871.x · Cited by 81
“Four classes of mammalian HDACs have been identified and classified based on homology to yeast HDACs (Gao et al. 2002; Morrison et al. 2006).”
Regulatory role of the 90-kDa-heat-shock protein (Hsp90) and associated factors on gene expression
Erlejman, A. G., Lagadari, M., Toneatto, J., Piwien‐Pilipuk, G., & Galigniana, M. D. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.12.006 · Cited by 86
Morris, M. J., & Monteggia, L. M. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.02.005 · Cited by 75
HDAC Inhibition and Graft Versus Host Disease
Choi, S. W., & Reddy, P. R. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00007 · Cited by 80
Adhikari, N., Jha, T., & Ghosh, B. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01676 · Cited by 74
Evolution of the arginase fold and functional diversity
Dowling, D. P., Di Costanzo, L., Gennadios, H. A., & Christianson, D. W. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7554-z · Cited by 74
Lin, L., Hou, J., Ma, F., Wang, P., Liu, X., Li, N., Wang, J., Wang, Q., & Cao, X. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203450 · Cited by 73
“Histone deacetylase 11 (HDAC11), the recently identified member of the HDAC family (7), has been shown to function as a crucial”
BackgroundVascular smooth muscle cell phenotypic plasticity: focus on chromatin remodelling
Spin, J. M., Mäegdefessel, L., & Tsao, P. S. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs098 · Cited by 78
“Class III HDACs, known as sirtuins (SIRTs 1–7), are NAD-dependent enzymes similar to yeast SIR2 proteins.50 Class IV is an atypical group that encompasses functional characteristics of Class I and II, and includes HDAC11.”
BackgroundLawlor, L., & Yang, X. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0053-2 · Cited by 80
Woods, D. M., Woan, K. V., Cheng, F., Sodré, A. L., Wang, D., Wu, Y., Wang, Z., Chen, J., Powers, J., Pinilla-Ibarz, J., et al. (2017) · Blood · doi:10.1182/blood-2016-08-731505 · Cited by 74
Histone Deacetylase Inhibitors: The Epigenetic Therapeutics That Repress Hypoxia‐Inducible Factors
Chen, S., & Sang, N. (2010) · BioMed Research International · doi:10.1155/2011/197946 · Cited by 82
“Class IV HDAC 11 Nucleus & cytoplasm Features of both classes I and II [61], Zinc independent”
Waltregny, D., North, B. J., Mellaert, F. V., de Leval, J., Verdin, E. M., & CASTRONOVO, V. (2004) · PubMed · doi:10.4081/897 · Cited by 77
Curcio, A., Rocca, R., Alcaro, S., & Artese, A. (2024) · Pharmaceuticals · doi:10.3390/ph17050620 · Cited by 81
“HDAC11, the sole HDAC isoenzyme in Class IV discovered in 2002, possesses significant fatty-acid deacylase activity and is recognized as a potential target for metabolic disorders [191–193].”
Lundh, M., Christensen, D. P., Rasmussen, D. N., Mascagni, P., Dinarello, C. A., Billestrup, N., Grunnet, L. G., & Mandrup-Poulsen, T. R. (2010) · Diabetologia · doi:10.1007/s00125-010-1892-8 · Cited by 74
“Class I and IIb KDACs are ubiquitously produced [17], class IIa is produced in cardiac and skeletal muscle (HDAC5 and -9) [18–20], and in the retina and skeletal growth plates (HDAC4) [21, 22] and thymocytes (HDAC7) [20], whereas HDAC11 is expressed in the brain, heart, skeletal muscle, kidney and testis [23, 24].”
BackgroundModulation of antigen‐presenting cells by HDAC inhibitors: implications in autoimmunity and cancer
Woan, K. V., Sahakian, E., Sotomayor, E. M., Seto, E., & Villagra, A. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.96 · Cited by 69
Targeting Histone Deacetylases: A Novel Approach in Parkinson’s Disease
Sharma, S., & Taliyan, R. (2015) · Parkinson's Disease · doi:10.1155/2015/303294 · Cited by 70
“Class IV (Zn2+ dependent) HDAC11 Cortex, hippocampus, brain stem, cerebellum, diencephalon Human, mouse, rat [21, 22, 34]”
Histone deacetylase modulators provided by Mother Nature
Seidel, C., Schnekenburger, M., Dicato, M. A., & Diederich, M. F. (2012) · Genes & Nutrition · doi:10.1007/s12263-012-0283-9 · Cited by 82
“This enzyme is structurally related to HDAC3 and 8 of class I, but also has similarities with class II; for these reasons, this new class of enzyme was created (Gao et al. 2002).”
Histone Modification Therapy of Cancer
Biancotto, C., Frigè, G., & Minucci, S. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380866-0.60013-7 · Cited by 86
Lapierre, M., Linarès, A., Dalvai, M., Duraffourd, C. C., Bonnet, S., Boulahtouf, A., Rodríguez, C., Jalaguier, S., Assou, S., Orsetti, B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7564 · Cited by 79
“Human HDACs form a large family of 18 members classified in four groups (I to IV) based on sequence homologies [5, 6].”
Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology
Sahakian, E., Chen, J., Powers, J. J., Chen, X., Maharaj, K., Deng, S. L., Achille, A. N., Lienlaf, M., Wang, H. W., Cheng, F., et al. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a0415-176rrr · Cited by 66
“HDAC11 is restricted mainly to the nucleus, and its expression appears to be tissue specific with higher expression in brain, heart, testis, and skeletal muscle [44]; however, its precise function in the myeloid compartment and specifically, in the neutrophils is yet to be elucidated.”
BackgroundHDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms
Yue, L., Sharma, V., Horvat, N. P., Akuffo, A. A., Beatty, M. S., Murdun, C., Colin, C., Billington, J. M. R., Goodheart, W. E., Sahakian, E., et al. (2020) · Blood · doi:10.1182/blood.2019895326 · Cited by 67
Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival
Thole, T. M., Lodrini, M., Fabian, J., Wuenschel, J., Pfeil, S., Hielscher, T., Kopp-Schneider, A., Heinicke, U., Fulda, S., Witt, O., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.49 · Cited by 67
“Gao et al.(24) identified and characterized HDAC11 in 2002, the only class IV HDAC family member identified to date, which is located within the ~25 kb region of chromosome 3p25.”
BackgroundInfluentialKamiya, T., Goto, A., Kurokawa, E., Hara, H., & Adachi, T. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1284372 · Cited by 76
Histone deacetylase complexes: Structure, regulation and function
Asmamaw, M. D., He, A., Zhang, L., Liu, H., & Gao, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189150 · Cited by 85
Acetylation and nuclear receptor action
Wang, C., Tian, L., Popov, V. M., & Pestell, R. G. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.12.003 · Cited by 76
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
Ružić, D., Djoković, N., Srdić‐Rajić, T., Echeverría, C., Nikolic, K. M., & Santibanez, J. F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010209 · Cited by 71
He, R., Chen, Y., Chen, Y., Ougolkov, A. V., Zhang, J.-S., Savoy, D. N., Billadeau, D. D., & Kozikowski, A. P. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901667k · Cited by 66
Lysine Acetylation and Deacetylation in Brain Development and Neuropathies
Tapias, A., & Wang, Z.-Q. (2017) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.09.002 · Cited by 66
“Class IV, one of the lessstudied KDAC groups, contains HDAC11 only, owing to the lack of homology with other KDACs [50].”
BackgroundMartin, M. W., Lee, J. Y., Lancia, D. R., Ng, P. Y., Han, B., Thomason, J. R., Lynes, M. S., Marshall, C. G., Conti, C., Collis, A., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.05.021 · Cited by 58
Chen, J., Shi, X., Padmanabhan, R., Wang, Q., Wu, Z., Stevenson, S. C., Hild, M., Garza, D., & Li, H. (2007) · Genome Research · doi:10.1101/gr.6940108 · Cited by 72
“Class II, and HDAC11 for both Class I and II (Barlow et al. 2001; Gao et al. 2002).”
BackgroundKirpich, I., Ghare, S. S., Zhang, J., Gobejishvili, L., Kharebava, G., Joshi‐Barve, S., Barker, D. F., Moghe, A., McClain, C. J., & Barve, S. S. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01751.x · Cited by 74
“HDAC11 possesses properties of HDACs Class I and Class II, and is classified as Class IV (Gao et al., 2002, Gregoretti et al., 2004).”
BackgroundChromatin unfolding by Cdt1 regulates MCM loading via opposing functions of HBO1 and HDAC11-geminin
Wong, P. G., Glozak, M. A., Cao, T. V., Vaziri, C., Seto, E., & Alexandrow, M. G. (2010) · Cell Cycle · doi:10.4161/cc.9.21.13596 · Cited by 77
“HDAC11 interacts with Cdt1 and localizes to replication origins specifically in S phase, and HDAC11 is capable of catalyzing the removal of acetylation from H4.”
BackgroundInfluentialSelective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands
Wood, T. E., Dalili, S., Simpson, C. D., Sukhai, M. A., Hurren, R., Anyiwe, K., Mao, X., Suárez, F., Gronda, M., Eberhard, Y., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0495 · Cited by 71
“To date, four classes of HDACs have been identified (5): class I (zinc-dependent enzymes showing homology to the yeast protein RPD3; HDAC1, HDAC2, HDAC3, and HDAC8), class II (zinc-dependent enzymes showing homology to the yeast protein HDA1; HDAC4, HDAC5, HDAC6, HDAC7, HDAC9, and HDAC10), class III (the structurally…”
BackgroundAnticancer Natural Compounds as Epigenetic Modulators of Gene Expression
Ratovitski, E. A. (2017) · Current Genomics · doi:10.2174/1389202917666160803165229 · Cited by 71
“Molecular mechanisms controlling cell cycle arrest, apoptosis, autophagy and necroptosis are closely related, so targeting these pathways simultaneously may help to induce the cell death of cancer cells and overcome the resistance of tumor cells to anticancer drugs [344-550].”
BackgroundChromatin remodeling and stem cell theory of relativity
Černý, J., & Quesenberry, P. J. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20071 · Cited by 67
“Recently, new members of the HDAC family, HDAC10 (Class II; Guardiola and Yao, 2002) and HDAC 11 (Class I; Gao et al., 2002), have been cloned.”
BackgroundTherapeutic effects of histone deacetylase inhibitors on heart disease
Chun, P. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01297-0 · Cited by 63
Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer
Giannopoulou, A. F., Velentzas, A. D., Konstantakou, E. G., Avgeris, M., Katarachia, S. A., Papandreou, N. C., Kalavros, N., Mpakou, V., Iconomidou, V. A., Anastasiadou, E., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061291 · Cited by 65
HDAC11 restricts HBV replication through epigenetic repression of cccDNA transcription
Yuan, Y., Zhao, K., Yao, Y., Liu, C., Chen, Y., Li, J., Wang, Y., Pei, R., Chen, J., Hu, X., et al. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.104619 · Cited by 64
GRHL1Acts as Tumor Suppressor in Neuroblastoma and Is Negatively Regulated by MYCN and HDAC3
Fabian, J., Lodrini, M., Oehme, I., Schier, M. C., Thole-Kliesch, T. M., Hielscher, T., Kopp‐Schneider, A., Opitz, L., Capper, D., von Deimling, A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1904 · Cited by 66
Bingel, C., Koeneke, E., Ridinger, J., Bittmann, A., Sill, M., Peterziel, H., Wrobel, J. K., Rettig, I., Milde, T., Fernekorn, U., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.398 · Cited by 65
Histone Deacetylation Inhibitors as Therapy Concept in Sepsis
von Knethen, A., & Brüne, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020346 · Cited by 63
“Class II a HDAC4, 5, 7, 9 [20–22] b HDAC6, 10 [21,23] Class IV HDAC11 [24]”
InfluentialPapeleu, P., Vanhaecke, T., Elaut, G., Vinken, M., Henkens, T., Snykers, S., & Rogiers, V. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440590935639 · Cited by 64
Parrella, P., Fazio, V. M., Gallo, A. P., Sidransky, D., & Merbs, S. L. (2003) · PubMed · Cited by 60
Weerasinghe, S. V. W., Estiu, G., Wiest, O., & Pflum, M. K. H. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800081j · Cited by 58
Bozkurt, E., Atmaca, H., Kısım, A., Uzunoğlu, S., Uslu, R., & Karaca, B. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.719658 · Cited by 57
Regulating Chromatin by Histone Acetylation
Steunou, A., Rossetto, D., & Côté, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8624-4_4 · Cited by 66
Targeting Epigenetic Mechanisms: Potential of Natural Products in Cancer Chemoprevention
Hauser, A., & Jung, M. (2008) · Planta Medica · doi:10.1055/s-2008-1081347 · Cited by 62
“This class I includes HDAC1, HDAC2, HDAC3 and HDAC8 [60].”
Histone deacetylases and atherosclerosis
Zheng, X., Zhou, T., Wang, X., Tong, X.-H., & Ding, J. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.048 · Cited by 63
HDACs and the epigenetic plasticity of cancer cells: target the complexity
Brancolini, C., Gagliano, T., & Minisini, M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108190 · Cited by 55
Thomas, E. (2014) · Pharmaceuticals · doi:10.3390/ph7060634 · Cited by 55
“Class IV is represented by a single member, HDAC11 [14], and while sharing similar characteristics to HDACs in classes I and II, HDAC 11 is thought to have a distinct physiological role [14,15].”
BackgroundGroh, I. A. M., Chen, C., Lüske, C. M., Cartus, A. T., & Esselen, M. (2013) · Journal of Nutrition and Metabolism · doi:10.1155/2013/821082 · Cited by 57
HDAC Inhibitors and Cancer Therapy
Atadja, P. W. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8989-5_9 · Cited by 63
“The Class IIa HDACs (HDACs 4, 5, 7, and 9) can shuttle between the nucleus and cytoplasm, and Class IIb HDACs (HDACs 6 and 7) are located primarily in the cytoplasm [7, 8]. HDAC11 is the sole member of Class IV, as it shares attributes of both Class I and II HDACs [ 9 , 10].”
BackgroundAcetyl-CoA metabolism as a therapeutic target for cancer
Chen, G., Bao, B., Cheng, Y., Tian, M., Song, J., Zheng, L., & Tong, Q. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115741 · Cited by 54
Transcriptional dysregulation in Huntington’s disease: The role of histone deacetylases
Sharma, S., & Taliyan, R. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.08.002 · Cited by 61
Thomas, E. A. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8067-y · Cited by 55
“Northern blotting, polymerase chain reaction, to demonstrate expression of certain HDAC subtypes in the brain and other peripheral tissues [70, 74, 75].”
BackgroundInfluentialLin, T. K., Chen, H., Koustova, E., Sailhamer, E. A., Li, Y., Shults, C., Liu, B., Rhee, P., Kirkpatrick, J. R., & Alam, H. B. (2007) · Surgery · doi:10.1016/j.surg.2007.01.014 · Cited by 55
An, C.-I., Dong, Y., & Hagiwara, N. (2011) · BMC Developmental Biology · doi:10.1186/1471-213x-11-59 · Cited by 65
“In spite of its high expression in skeletal muscle, the role of the class IV histone deacetylase Hdac11 [50] in muscle development is yet to be discovered [51].”
BackgroundHistone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53
Mrakovcic, M., Kleinheinz, J., & Fröhlich, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091883 · Cited by 51
“HDAC11 is the only class IV HDAC representative that was added as the last category [61]; it possesses narrowed tissue expression and is less well investigated in its function.”
BackgroundRole of Sirtuin 1 in the pathogenesis of ocular disease (Review)
Zhou, M., Luo, J., & Zhang, H. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3623 · Cited by 67
“According to the homologies of the respective yeast orthologues, human HdAcs have been divided into four classes (3,4).”
Repurposing Vorinostat for the Treatment of Disorders Affecting Brain
Athira, K. V., Sadanandan, P., & Chakravarty, S. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-021-08660-4 · Cited by 59
“Class IV contains only one member, HDAC11, whose function is much less illustrated (Gao et al., 2002).”
BackgroundHDAC11, an emerging therapeutic target for metabolic disorders
Chen, H., Xie, C., Chen, Q., & Zhuang, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.989305 · Cited by 61
Kizuka, Y., Kitazume, S., Okahara, K., Villagra, A., Sotomayor, E. M., & Taniguchi, N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554311 · Cited by 64
“Hdac11 is known to be highly expressed in brain, kidney, heart, and muscle (34), and in brain HDAC11 was reported to regulate oligodendrocyte-specific gene expression (35).”
BackgroundEpigenetics and autosomal dominant polycystic kidney disease
Li, X. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.10.008 · Cited by 56
Sirtuins, nuclear hormone receptor acetylation and transcriptional regulation
Whittle, J. R., Powell, M. J., Popov, V. M., Shirley, L. A., Wang, C., & Pestell, R. G. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.07.007 · Cited by 51
The role and molecular mechanism of epigenetics in cardiac hypertrophy
Lei, H. C., Hu, J., Sun, K., & Xu, D. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09959-3 · Cited by 53
Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents
Budillon, A., Gennaro, E. D., Bruzzese, F., Rocco, M., Manzo, G., & Caraglia, M. (2007) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489207780832450 · Cited by 57
HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2
Scognamiglio, A., Nebbioso, A., Manzo, F., Valente, S., Mai, A., & Altucci, L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.007 · Cited by 56
Histone deacetylase inhibition in the treatment of heart disease
Berry, J. M., Cao, D. J., Rothermel, B. A., & Hill, J. A. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.1.53 · Cited by 54
“HDAC11 shares conserved residues within the catalytic core region with class I and II HDACs [60] .”
BackgroundEpigenetic Targeting of Histone Deacetylases in Diagnostics and Treatment of Depression
Park, H., Kim, J., Ahn, S. H., & Ryu, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105398 · Cited by 58
“It is primarily expressed in the brain, skeletal muscle, heart, testis, and kidney, suggesting specific functions in development, inflammation, metabolism [55].”
BackgroundEpigenetic mechanisms of plant-derived anticancer drugs
Schneider‐Stock, R., Ghantous, A., Bajbouj, K., Saikali, M., & Darwiche, N. (2011) · Frontiers in bioscience · doi:10.2741/3919 · Cited by 50
Wambua, M. K., Nalawansha, D. A., Negmeldin, A. T., & Pflum, M. K. H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401837e · Cited by 52
Therapeutic effects of histone deacetylase inhibitors on kidney disease
Chun, P. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0998-7 · Cited by 52
Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment
Barnes, P. J. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.6.1111 · Cited by 51
“Just as acetylation of histones is associated with gene induction, removal of acetyl groups by HDACs is associated with repacking of chromatin and a lack of gene expression or gene silencing [17].”
BackgroundXu, Y., Sengupta, P. K., Seto, E., & Smith, B. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511724200 · Cited by 54
Association of histone deacetylase genes with schizophrenia in Korean population
Kim, T., Park, J. K., Kim, H., Chung, J., & Kim, J. W. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.05.007 · Cited by 53
“Although HDAC11 has been identified, it has not yet been classified (Gao et al., 2002).”
BackgroundHistone Deacetylase 3 Is Required for Efficient T Cell Development
Stengel, K. R., Zhao, Y., Klus, N. J., Kaiser, J. F., Gordy, L. E., Joyce, S., Hiebert, S. W., & Summers, A. R. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00706-15 · Cited by 48
“HDAC11 is the only member of the 4th class of deacetylase and modulates immunity (14, 15).”
BackgroundSodium Butyrate Controls Cardiac Hypertrophy in Experimental Models of Rats
Patel, B. M. (2017) · Cardiovascular Toxicology · doi:10.1007/s12012-017-9406-2 · Cited by 48
Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model
Sun, L., Telles, E., Karl, M. T., Cheng, F., Luetteke, N., Sotomayor, E. M., Miller, R. H., & Seto, E. (2018) · Life Science Alliance · doi:10.26508/lsa.201800039 · Cited by 53
Cadet, J. L., & Jayanthi, S. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105069 · Cited by 50
Bruserud, Ø., Stapnes, C., Tronstad, K. J., Ryningen, A., Ånensen, N., & Gjertsen, B. T. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.51 · Cited by 49
“• Class IV, with HDAC 11 being the only member; this molecule has conserved residues in the catalytic core that are shared both by class I and class II enzymes [15,16].”
BackgroundHDAC11 is a novel regulator of fatty acid oxidative metabolism in skeletal muscle
Hurtado, E., Núñez‐Álvarez, Y., Muñoz, M., Gutiérrez‐Caballero, C., Casas, J., Pendás, A. M., Peinado, M. A., & Suelves, M. (2020) · FEBS Journal · doi:10.1111/febs.15456 · Cited by 47
Writers, Readers, and Erasers of Epigenetic Marks
Nicholson, T. B., Veland, N., & Chen, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800206-3.00003-3 · Cited by 58
HDAC11 Inhibits Myoblast Differentiation through Repression of MyoD-Dependent Transcription
Byun, S. K., An, T. H., Son, M. J., Lee, D. S., Kang, H. S., Lee, E., Han, B., Kim, W. K., Bae, K., Oh, K., et al. (2017) · Molecules and Cells · doi:10.14348/molcells.2017.0116 · Cited by 47
“HDAC11 has recently been identified as a unique member of the class IV HDAC, consisting of only a catalytic domain (Gao et al., 2002; Haberland et al., 2009; Voelter et al., 2005).”
BackgroundAmin, S. A., Adhikari, N., Kotagiri, S., Jha, T., & Ghosh, B. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.077 · Cited by 42
Regulation of Osteoclast Differentiation and Skeletal Maintenance by Histone Deacetylases
Faulkner, B., Astleford, K., & Mansky, K. C. (2019) · Molecules · doi:10.3390/molecules24071355 · Cited by 43
“It shares a similar structure to that of the class I HDACs; however, little is known about the mechanism by which HDAC11 regulates transcription [60].”
BackgroundInfluentialKulka, L. A. M., Fangmann, P.-V., Panfilova, D., & Olzscha, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00425 · Cited by 44
Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy
Ding, P., Ma, Z., Liu, D., Pan, M., Li, H., Feng, Y., Zhang, Y., Shao, C., Jiang, M., Lu, D., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.865975 · Cited by 52
“The two subclasses are closely related to Hda1 in yeast and can move back and forth between the cytoplasm and the nucleus, allowing Class II HDACs to regulate cytoplasmic substrates (29, 30).”
BackgroundDoherty, R., O’Farrelly, C., & Meade, K. G. (2013) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2013.05.004 · Cited by 54
Multi-targeted HDAC Inhibitors as Anticancer Agents: Current Status and Future Prospective
Patel, V. K., Shirbhate, E., Tiwari, P., Kore, R., Veerasamy, R., Mishra, A., & Rajak, H. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220922105615 · Cited by 47
Wright, L. H., & Menick, D. R. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00271.2016 · Cited by 43
Targeting histone deacetylases for heart failure
Bush, E. W., & McKinsey, T. A. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902939161 · Cited by 43
“Class IIb HDACs: mediators of tubulin and aggresome function First identified as a tubulin deacetylase [6], HDAC6 is closely associated with the other, less well-characterized class IIb HDAC, HDAC10 [4].”
InfluentialEpigenetic regulation of extracellular-superoxide dismutase in human monocytes
Kamiya, T., Machiura, M., Makino, J., Hara, H., Hozumi, I., & Adachi, T. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.013 · Cited by 41
Shaping the oligodendrocyte identity by epigenetic control
Yu, Y., Casaccia, P., & Lu, Q. R. (2010) · Epigenetics · doi:10.4161/epi.5.2.11160 · Cited by 46
Watanabe, Y., Khodosevich, K., & Monyer, H. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.022 · Cited by 43
“, 2013), but not HEK293 cells, express Hdac11 (Gao et al., 2002).”
BackgroundInfluentialHistone deacetylase inhibitors: a patent review (2009 – 2011)
Carafa, V., Miceli, M., Altucci, L., & Nebbioso, A. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.736493 · Cited by 42
Histone deacetylases 1 and 2 are required for brain development
Jaworska, J., Ziemka‐Nałęcz, M., & Zalewska, T. (2015) · The International Journal of Developmental Biology · doi:10.1387/ijdb.150071tz · Cited by 48
“…loss of subcutaneous fat, degenerative cardiac hypertrophy), increased apoptosis NR Nakagawa and Guarente 2011 Class IV Zn2+ HDAC 11 Nucleus NR Gao et al. 2002 NR TABLE 1 CLASSIFICATION AND PHENOTYPES OF WHOLE BODY AND BRAIN-SPECIFIC KNOCKOUTS (KO) OF HISTONE DEACETYLASE (HDAC) ISOFORMS NR…”
BackgroundHistone Deacetylase Inhibitors and Rational Combination Therapies
Grant, S., & Dai, Y. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-394387-3.00006-9 · Cited by 50
Amin, S. A., Adhikari, N., & Jha, T. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0130 · Cited by 45
“The class IV HDAC (HDAC-11) is solely based on its DNA sequence similarity to others and the catalytic core region is conserved similar with both classes I and II HDACs [16].”
Metadata
- Authors
- Gao, L., Cueto, M. A., Asselbergs, F., & Atadja, P.
- Affiliations
- Novartis (United States) (US)
- Corresponding author
- Atadja, Peter
- ORCID
- Gao, Lin
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-07
- Volume
- 277
- Issue
- 28
- Pages
- 25748-25755
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2070089404
- Cited by
- 744
- References
- 43
- Citations by year
- 2026: 27 · 2025: 28 · 2024: 32 · 2023: 36 · 2022: 31 · 2021: 33 · 2020: 43 · 2019: 26 · 2018: 30 · 2017: 36 · 2016: 30 · 2015: 41 · 2014: 34 · 2013: 30 · 2012: 37
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6687 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- HDAC11, histone deacetylase, cDNA cloning, histone deacetylase activity, tissue expression, nuclear localization, protein complexes, evolutionary conservation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cloning, Molecular, Histone Deacetylases, Humans, Molecular Sequence Data, Nuclear Proteins, RNA, Messenger, Sequence Homology, Amino Acid, DNA, Complementary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.